CN1995036B - 光学纯α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 - Google Patents
光学纯α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 Download PDFInfo
- Publication number
- CN1995036B CN1995036B CN2006100000736A CN200610000073A CN1995036B CN 1995036 B CN1995036 B CN 1995036B CN 2006100000736 A CN2006100000736 A CN 2006100000736A CN 200610000073 A CN200610000073 A CN 200610000073A CN 1995036 B CN1995036 B CN 1995036B
- Authority
- CN
- China
- Prior art keywords
- compound
- methyl
- preparation
- carbon atom
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
药物 | 脆弱拟菌 | 普雷活菌卟啉菌 | 梭杆菌 | 消化链球菌 | 梭菌 | 无芽胞G杆菌 |
阿莫西林/克拉维酸 | +++ | +++ | +++ | +++ | +++ | +++ |
氨苄西林/舒巴坦 | +++ | +++ | +++ | +++ | +++ | +++ |
替卡西林/克拉维酸 | +++ | +++ | +++ | +++ | +++ | +++ |
哌拉西林/三唑巴坦 | +++ | ++/+++ | +++ | +++ | +++ | +++ |
头孢哌酮/舒巴坦 | +++ | +++ | +++ | +++ | + | ++ |
亚胺培南/西司他汀 | +++ | +++ | +++ | +++ | +++ | +++ |
氯霉素 | +++ | +++ | +++ | +++ | +++ | +++ |
甲硝唑 | +++ | +++ | +++ | +++ | +++ | -/++ |
克林霉素 | ++ | ++/+++ | +++ | +++ | ++ | ++/+++ |
青霉素G | - | -/+ | +++ | +++ | +++ | +++ |
哌拉西林 | ++ | ++/+++ | +++ | +++ | +++ | +++ |
头孢西丁 | ++ | ++/+++ | +++ | +++ | ++ | +++ |
头孢替坦 | ++ | ++/+ | ++ | +++ | ++ | ++ |
药物 | 脆弱拟菌 | 普雷活菌卟啉菌 | 梭杆菌 | 消化链球菌 | 梭菌 | 无芽胞G杆菌 |
头孢唑肟 | ++ | ++/+++ | +++ | +++ | + | ++/+++ |
拉氧头孢 | ++ | +/+++ | ++ | +++ | ++ | ++ |
化合物(实施例) | 口服2000mg/kg死亡率 | 腹腔注射2000mg/kg死亡率 |
化合物1 | 0 | 0 |
化合物2 | 0 | 0 |
奥硝唑 | 5 | 7 |
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100000736A CN1995036B (zh) | 2006-01-06 | 2006-01-06 | 光学纯α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 |
PCT/CN2006/003579 WO2007079653A1 (en) | 2006-01-06 | 2006-12-25 | OPTICALLY PURE α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOLE-1-ETHANOL DERIVATIVES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100000736A CN1995036B (zh) | 2006-01-06 | 2006-01-06 | 光学纯α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1995036A CN1995036A (zh) | 2007-07-11 |
CN1995036B true CN1995036B (zh) | 2010-04-14 |
Family
ID=38250254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100000736A Active CN1995036B (zh) | 2006-01-06 | 2006-01-06 | 光学纯α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1995036B (zh) |
WO (1) | WO2007079653A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106674124A (zh) * | 2015-11-09 | 2017-05-17 | 陕西合成药业股份有限公司 | 一种盐酸左旋吗啉硝唑晶型及其制备方法和用途 |
CN106699669A (zh) * | 2015-11-18 | 2017-05-24 | 陕西合成药业股份有限公司 | 一种左旋吗啉硝唑晶型及其制备方法和药用组合物的用途 |
CN111973569A (zh) * | 2019-05-21 | 2020-11-24 | 江苏豪森药业集团有限公司 | 含有硝基咪唑类衍生物的药物组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1982306A (zh) * | 2005-12-15 | 2007-06-20 | 南京圣和药业有限公司 | 光学活性的α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100344626C (zh) * | 2003-10-08 | 2007-10-24 | 连云港恒邦医药科技有限公司 | α-(吗啉-1-基)甲基-2-甲基-5-硝基咪唑-1-乙醇用于制备抗厌氧菌药物的用途 |
WO2006058457A1 (fr) * | 2004-11-30 | 2006-06-08 | Lianyungang Hengbang Pharmaceutical Co. Ltd. | DÉRIVÉS DE 2-MÉTHYL-5-NITROIMIDAZOL-1-ÉTHANOL α-SUBSTITUÉS |
CN1789250A (zh) * | 2005-12-16 | 2006-06-21 | 西安新安医药科技有限公司 | 一组硝基咪唑类衍生物的光学对映体、制备方法及其用途 |
CN100387233C (zh) * | 2006-06-09 | 2008-05-14 | 南京圣和药业有限公司 | 左旋吗啉硝唑在制备抗寄生虫感染药物中的用途 |
-
2006
- 2006-01-06 CN CN2006100000736A patent/CN1995036B/zh active Active
- 2006-12-25 WO PCT/CN2006/003579 patent/WO2007079653A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1982306A (zh) * | 2005-12-15 | 2007-06-20 | 南京圣和药业有限公司 | 光学活性的α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 |
Also Published As
Publication number | Publication date |
---|---|
WO2007079653A1 (en) | 2007-07-19 |
CN1995036A (zh) | 2007-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1288050C (en) | Nitrofurantoin dosage form | |
US20070155679A1 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations | |
CN101014340A (zh) | 微囊形式的基于抗生素的药物制剂 | |
JP2002541107A (ja) | トルペリソンを含有する経口投与のための薬学的製剤 | |
CN1995036B (zh) | 光学纯α-取代的2-甲基-5-硝基咪唑-1-乙醇衍生物 | |
CN100344626C (zh) | α-(吗啉-1-基)甲基-2-甲基-5-硝基咪唑-1-乙醇用于制备抗厌氧菌药物的用途 | |
CN1046459A (zh) | 剂量形式的美贝维林 | |
JP2002512961A (ja) | 外陰膣炎および膣症を局所的に治療するための医薬品イミダゾールの併用 | |
JPH11510191A (ja) | 5―asaを含有する修飾放出性経口医薬組成物および腸疾患の治療方法 | |
EP1596841B1 (en) | Therapeutic system comprising amoxicillin and clavulanic acid | |
CN100427094C (zh) | α-(吗啉-1-基)甲基-2-甲基-5-硝基咪唑-1-乙醇在制备抗滴虫、抗阿米巴原虫药物的用途 | |
CN106822034A (zh) | 以玉米芯粉为囊心材料制备含药物的囊心物或微囊 | |
CN103145733B (zh) | 一种阿莫西林化合物及该化合物和克拉维酸钾的药物组合物 | |
CN110075082A (zh) | 一种恩诺沙星速释微丸及其制备方法 | |
CN107375247B (zh) | 替米考星膜控肠溶缓释制剂及其制备方法 | |
CN107115325A (zh) | 一种琥珀酸呋罗曲坦胶囊及其制备方法 | |
WO2006058457A1 (fr) | DÉRIVÉS DE 2-MÉTHYL-5-NITROIMIDAZOL-1-ÉTHANOL α-SUBSTITUÉS | |
US20240041782A1 (en) | Oral Capsule Cannabinoid Formulations | |
WO2009076243A2 (en) | Novel uses of chloramphenicol and analogues thereof | |
CN1281447A (zh) | (e)-3-[1-正丁基-5-[2-(2-羧基苯基)甲氧基-4-氯苯基]-1h-吡唑-4-基]-2-[(5-甲氧基-2,3-二氢苯并呋喃-6-基)甲基]丙-2-烯酸-精氨酸盐 | |
CN101190890B (zh) | 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 | |
CN1981743A (zh) | 一种结肠定位释放微丸及其制备方法 | |
CN100368403C (zh) | 一种抗厌氧菌化合物 | |
CN116725985B (zh) | 一种微丸组合乌拉地尔缓释胶囊及其制备方法 | |
US11970466B1 (en) | 4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoic acid as an antimicrobial compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20081205 Address after: Postal code of Lianyungang economic and Technological Development Zone, Jiangsu 222047, China Applicant after: Lianyungang Hengbang Pharmaceutical Technology Co., Ltd. Address before: Tenth Industrial Zone, Lianyungang Development Zone, Jiangsu Province, China: 222047 Applicant before: Jiangsu Haosen Pharmaceutical Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: LIANYUNGANG HENGBANG PHARMACEUTICAL TECHNOLOGY CO. Free format text: FORMER OWNER: JIANGSU HAOSEN PHARMACEUTICAL CO., LTD. Effective date: 20081205 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU HANSOH MEDICAL GROUP CO.,LTD. Free format text: FORMER OWNER: LIANYUNGANG HENGBANG PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20131113 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131113 Address after: 222047 Lianyungang Development Zone, Jiangsu Patentee after: Jiangsu Hansoh Medical Group Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee before: Lianyungang Hengbang Pharmaceutical Technology Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160315 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. Address before: 222047 Lianyungang Development Zone, Jiangsu Patentee before: Jiangsu Hansoh Medical Group Co.,Ltd. |